Eu Ivdd Eu Ivd General On The Market 🇰🇷 South Korea

FREND™ COVID-19 Neutralization Ab

NanoEntek, Inc. · 🇰🇷 South Korea
Devices (same UDI-DI)
1
Certificates
0
Countries
2
Notified Bodies
0

Basic Information

Primary DI
08809317541075
Basic UDI-DI Code
B-08809317541075
Reference
FRCON 020
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market
Manufacturer
NanoEntek, Inc.

Additional Description

The FREND™ COVID-19 Neutralization Ab is a point-of-care testing (POCT) which can be used to check whether a patient has developed the immune response to SARS-CoV-2 using human serum and plasma (EDTA). The FREND™ COVID-19 Neutralization Ab is a fluorescence immunoassay (FIA) using the FREND™ System intended for the qualitative detection of neutralization antibodies to SARS-CoV-2. The FREND™ COVID-19 Neutralization Ab is an in vitro diagnostic medical device which is intended for use as an aid in identifying individuals with neutralizing antibodies to SARS-CoV-2 after vaccination or prior infection.

CND Nomenclature Codes

Code Description
W0105040699 VIRAL ANTIGEN/ANTIBODY DETECTION - OTHER

Available In Countries

🇩🇪 Germany 🇷🇴 Romania

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all